Hypercholesterolemia frequently accompanies hypertension, and it has been suggested that by affecting membrane lipid composition, hypercholesterolemia may cause or accentuate abnormalities in several red blood cell transports associated with hypertension. Such an effect might obfuscate the relation of membrane markers to hypertension and decrease their usefulness in genetic studies of the heritable basis of hypertension. To determine if changing plasma lipids affects membrane transport, we studied the effects of the cholesterol-lowering agent lovastatin on red blood cell lithium-sodium countertransport and sodium-potassium-chloride cotransport, red blood cell sodium and water content, and platelet amiloride-sensitive volume responsiveness to cytoplasmic acidification, an indirect measure of sodium-proton exchange that has been proposed as a new membrane marker for hypertension. In a 24 -week, placebo-controlled, double-blinded, randomized trial, lovastatin significantly lowered total and low density lipoprotein cholesterol and raised high density lipoprotein cholesterol. Red blood cell lithium-sodium countertransport and sodium-potassium-chloride cotransport were not significantly altered. Red blood cell sodium content decreased significantly in the lovastatintreated group, probably as a result of an increase in red blood cell sodium-potassium pump activity. Platelet amiloride-sensitive responses to cytoplasmic acidification were significantly depressed by lovastatin treatment, suggesting that lowering plasma cholesterol may suppress platelet sodium-proton exchange. It has been hypothesized that the hypeiiipidemias frequently observed in essential hypertensive patients may alter membrane lipid composition and affect membrane cation transport activities. Our observations on the effects of lovastatin treatment suggest that the abnormalities in lithium-sodium countertransport and sodium-potassiumchloride cotransport associated with human essential hypertension are unlikely to result from altered membrane cholesterol content or membrane cholesterol/phospholipid ratio. Altered membrane lipid composition may affect the sodium-potassium pump or sodium-proton antiport. olism cause or at least contribute to the increased Vnu,, for RBC Li + -Na + countertransport in hypertension.8 However, it is equally plausible that high total or low HDL cholesterol and hypertension are both features of a common underlying defect, such as that which may cause the syndrome characterized by Williams et al 9 as familial dyslipidemic hypertension. If an increased V,^ for RBC Li + -Na + countertransport is a marker for a genetic predisposition to familial dyslipidemic hypertension or related hypercholesterolemia syndromes, 10 then increased RBC Li + -Na + countertransport, hyperlipidemia, and hypertension could all be interrelated, but lipid levels per se would not necessarily contribute to elevated RBC Li + -Na + countertransport activity.We measured RBC Li + -Na + countertransport activity and plasma lipid levels in patients before and aft...